Treatment of NIDDM in Youth
- 1 February 1998
- journal article
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 37 (2) , 117-121
- https://doi.org/10.1177/000992289803700209
Abstract
This study presents the characteristics of 20 children (17 female) with NIDDM who required oral hypoglycemic agent (OHA) therapy. A family history of NIDDM was present in 55%. None had islet cell antibodies (ICA) or glutamic acid decarboxylase (GAD) antibodies. Tolbutamide was the drug of choice; glibenclamide was introduced if glycemic control was not obtained after 2 to 3 months of tolbutamide therapy. Seven of the patients eventually required insulin therapy. Clin Pediatr. 1998;37:117-122Keywords
This publication has 5 references indexed in Scilit:
- Epidemiology of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in Japanese childrenDiabetes Research and Clinical Practice, 1994
- Descriptive Epidemiology of Non‐Insulin Dependent Diabetes Mellitus Detected by Urine Glucose Screening in School Children in JapanPediatrics International, 1990
- Scope and Heterogeneous Nature of MODYDiabetes Care, 1990
- Type 1 (insulin-dependent) diabetes in Japanese children is not a uniform diseaseDiabetologia, 1989
- Tolbutamide-induced Improvement in Carbohydrate Tolerance of Young People with Mild Diabetes MellitusDiabetes, 1960